… [GLP], and good clinical laboratory practice [GCLP] compliance). High-resolution MS is indeed a powerful tool … [GLP], and good clinical laboratory practice [GCLP] compliance). High-resolution MS is indeed a powerful tool …
… Due to their mode of production, therapeutic mAbs present diverse and heterogeneous glycosylations. Their … release and DMBlabelling, starting from small amounts of mAbs. The results are consistent with the N-glycosylation … what was found by released glycans analysis. Analysis of mAbs subunits, generated by IdeS enzyme digestion, followed …
… Biologics and in particular monoclonal antibodies (mAbs) are an important class of therapeutics, and their market is growing. The production of mAbs is a complex and lengthy process. In-process …
… professionals to accelerate therapeutics drugs such as mAbs , vaccines , cell therapy and novel products into … of their extensive experience with the analysis of mAbs. Throughout non-clinical and clinical development, our …
… professionals to accelerate therapeutics drugs such as mAbs , vaccines , cell therapy and novel products into … assistance is an expert for the development of: NBEs ( mAbs , ADCs , proteins ) NCEs , oligonucleotides , …